Company / Financials
UTAH MEDICAL PRODUCTS INC Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$50.2M
FY2025 · -3.9% YoY
Net Income
$16.6M
FY2025 · +1.0% YoY
Profit Margin
33.1%
FY2025 · net income / revenue
ROE
14.0%
FY2025 · return on equity
Total Assets
$122.5M
FY2025
Total Debt
-
FY2025
Equity
$119.3M
FY2025
ROA
13.6%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$50.2M-3.9% YoYNet Income HistoryProfit after all expenses and taxes$16.6M+1.0% YoYGross Profit HistoryRevenue minus cost of goods sold$30.0M-6.7% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$20.2M+0.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes$16.8M-15.2% YoYSG&A Expense HistorySelling, general, and administrative expenses$11.0M+5.9% YoYR&D Expense HistoryResearch and development spending$560.0K+13.6% YoYInterest Expense HistoryCost of borrowing and debt obligations$65.0KIncome Tax HistoryTotal income tax expense$3.5M-17.5% YoYEPS (Basic) HistoryBasic earnings per share$4.58+1.1% YoY